06.08.17
Chiltern, a global CRO, has released its new Medidata Rave Value Accelerators, a system of tools designed to capture, manage and report clinical research data. The tools aim to streamline the clinical trial process.
“Our partnership with Medidata and its industry-leading platform aligns with our strategy providing an exceptional customer experience around best-in-class technologies,” said Mark Penniston, executive vice president, clinical analytics, and general manager at Chiltern. “Currently our Data & Analysis team leads the field in providing the latest platforms and technologies and the Medidata Rave Value Accelerators support our stronghold in the technology space.”
The three accelerator tools include: the Chiltern EC Reviewer for Medidata Rave, Chiltern EC Detector for Medidata Rave and Chiltern EC Analyzer for Medidata Rave. They are designed to create flexibility for users, helping them accommodate their workflow environments, and they are scalable from one study to hundreds and from Phase I to global Phase IV studies.
These allow sponsors to select which tools are appropriate for their needs and can be used anytime and anywhere, and by multiple users during the setup and conduct of the trial.
“Our partnership with Medidata and its industry-leading platform aligns with our strategy providing an exceptional customer experience around best-in-class technologies,” said Mark Penniston, executive vice president, clinical analytics, and general manager at Chiltern. “Currently our Data & Analysis team leads the field in providing the latest platforms and technologies and the Medidata Rave Value Accelerators support our stronghold in the technology space.”
The three accelerator tools include: the Chiltern EC Reviewer for Medidata Rave, Chiltern EC Detector for Medidata Rave and Chiltern EC Analyzer for Medidata Rave. They are designed to create flexibility for users, helping them accommodate their workflow environments, and they are scalable from one study to hundreds and from Phase I to global Phase IV studies.
These allow sponsors to select which tools are appropriate for their needs and can be used anytime and anywhere, and by multiple users during the setup and conduct of the trial.
